An effective treatment for #Coronavirus #COVID-19 has been found in a common anti-malarial drug Anthony Watts / 13 hours ago Encouraging news: three new medical studies show a commonly available anti-malaria drug known as chloroquine aka chloroquine phosphate is showing strong results against COVID-19 infections in both China and South Korea... A commonly available over-the-counter quinine source exists in Margosa Tree Bark and Cinchona succirubra, Peruvian Bark Tablets of bark extract are widely available in tablet form, from many sources, including Amazon.com here.There’s also quinine in Tonic Water, which is available just about anywhere at any grocery or liquor store and also at Amazon: Tonic water is a soft drink containing quinine, which gives it a bitter taste. Quinine is a common treatment for malaria. Quinine comes from the bark of the cinchona tree." Breitbart metallurgy expert James Delingpole offers this galvanizing explanation : The reason that Chloroquine works, I understand from an expert in viral pandemics, is that enables the body to absorb more zinc. Zinc appears to be the most effective agent in disrupting the virus and preventing the ‘cytokine storm’, which is the deadly phase in which the virus tricks the body’s immune system into attacking its own healthy tissue, with often fatal consequences. BEFORE INDULGING, NOTE THAT WATTS & DELINGPOLE 1. ARE TOUTING THE WRONG DRUG- NATURE IS TALKING ABOUT HYDROXYCHLOROQUINE, NOT QUININE 2.SYNTHETIC CHLOROQUINE AND HYDROXYCHLOROQUINE DON'T GROW ON TREES. 3. NEITHER IS FOUND IN TONIC WATER, OR FOR THAT MATTER, GIN. 4. INGESTING TWO GRAMS OF CHLOROQUINE CAN BE FATAL WIKIPEDIA REPORTS: Chloroquine and hydroxychloroquine has been recommended by Chinese, South Korean and Italian health authorities for the treatment COVID-19. In February 2020, it was shown to effectively inhibit COVID-19 in vitro.Preliminary results from a multicentric trial, announced in a press conference and described by Gao, Tian and Yang, suggested that chloroquine is effective and safe in treating COVID-19 associated pneumonia, "improving lung imaging findings, promoting a virus-negative conversion, and shortening the disease course". On 16 March 2020, advisor to the French Government on COVID-19, Professor Didier Raoult, announced that a trial involving 24 patients from the south east of France supported the claim that chloroquine was an effective treatment for COVID-19. 600mg of hydroxychloroquine (brand name Plaquenil) was administered to these patients every day for 10 days. The drug appeared to be responsible for a "rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious". In Australia, the Director of the University of Queensland Centre for Clinical Research, Professor David Paterson, announced his intention to conduct a large clinical trial of the efficacy of both chloroquine and lopinavir/ritonavir as treatments for COVID-19.